What question did this study set out to answer?

To evaluate the effects of equol on basophil activation and its potential as an anti-allergic agent.

February 16, 2026

Equol, a Metabolite of Daidzein, Inhibits IgE-Dependent Basophil Activation by Modulating Intracellular Signaling

To evaluate the effects of equol on basophil activation and its potential as an anti-allergic agent.
In vitro experiments assessing the role of equol in IgE-dependent basophil activation.
Analysis of intracellular signaling pathways modulated by equol.
Equol significantly inhibits IgE-dependent basophil activation.
The findings support the potential of equol and isoflavones as anti-allergic agents.

These results suggest that equol might be a potential candidate as an anti-allergic agent as well as related isoflavones.

Perguntar à IA

Bookmark

View Full Paper

Yamaki et al. (Fri,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper